ABL Bio Inc. (KOSDAQ:298380)
111,200
+7,900 (7.65%)
Nov 4, 2025, 3:30 PM KST
7.65% (1Y)
| Market Cap | 6.13T |
| Revenue (ttm) | 94.93B |
| Net Income (ttm) | -20.52B |
| Shares Out | 55.13M |
| EPS (ttm) | -425.01 |
| PE Ratio | n/a |
| Forward PE | 186.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,121,602 |
| Average Volume | 632,306 |
| Open | 100,700 |
| Previous Close | 103,300 |
| Day's Range | 99,500 - 114,000 |
| 52-Week Range | 25,950 - 112,800 |
| Beta | 0.71 |
| RSI | 65.45 |
| Earnings Date | Nov 10, 2025 |